Keskin, M. Et Al. 2012. Importance of serum VEGF and basic FGF levels in determining response to treatment and survival in patients with metastatic colorectal cancer.. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Keskin, M., Ustuner, Z., Dincer, M., ETİZ, D., Celik, H. E., & Gulbas, Z., (2012). Importance of serum VEGF and basic FGF levels in determining response to treatment and survival in patients with metastatic colorectal cancer. . 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Keskin, Muge Et Al. "Importance of serum VEGF and basic FGF levels in determining response to treatment and survival in patients with metastatic colorectal cancer.," 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2012

Keskin, Muge Et Al. "Importance of serum VEGF and basic FGF levels in determining response to treatment and survival in patients with metastatic colorectal cancer.." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2012

Keskin, M. Et Al. (2012) . "Importance of serum VEGF and basic FGF levels in determining response to treatment and survival in patients with metastatic colorectal cancer.." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Muge Keskin Et Al. }, title={Importance of serum VEGF and basic FGF levels in determining response to treatment and survival in patients with metastatic colorectal cancer.}, congress name={48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2012}}